In the past 10 years, 14 companies have unsuccessfully attempted to secure FDA approval for an ocular surface drug. Interestingly, many of these drugs have been approved for use in Asia and/or Europe and have been commercially successful.Click here to read more about why dry eye trials often fail:
Dry eye disease is one of the most common conditions seen by eye care providers, however its diagnosis is still difficult due to a lack of consistent disease identification criteria. This paper provides information on current diagnostic testing and management strategies in order to help...
Many commonly prescribed medications produce ocular side effects. This article presents common side effects of several drug classes. Click here to learn more:
The optometrist is very crucial to the detection of Sjogren’s Syndrome. This article discusses the proper time to send out patients with Sjogrens
Read more here….
Topical application of a the new drug Kineret used to treat Rheumatoid Arthritis has been shown to treat the symptoms of dry eye. This article discusses the study conducted to research the benefits of this drug on dry eye.
Read more here…
Meibomian gland dysfunction is a very common condition observed in clinic. This article discusses the emerging treatment options for meibomian gland dysfunction
Read more here…
